Physician profile
Esther Ringel
NPI 1487134201
$1,975.04
in general payments reported to CMS, 2019-2025
12 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $277 · 2022: $392 · 2023: $546 · 2024: $265 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,206 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.18 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $672.22 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $381.44 | 2021-2023 | Farxiga, Lokelma, Brilinta |
| Pfizer INC. | $254.02 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $119.00 | 2024-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $97.04 | 2021-2022 | |
| Genzyme Corporation | $88.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $61.61 | 2022-2024 | Eliquis |
| Csl Behring | $59.50 | 2024-2025 | Kcentra |
| Janssen Pharmaceuticals, INC | $55.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.72 | 2023 | |
| Amgen INC. | $30.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Ringel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.